As of July 2025, Long COVID, also known as post-acute sequelae of COVID-19 (PASC), affects millions globally, with an estimated 400 million cases worldwide, including 1.8% of the UK population and 4–10% of US adults. Defined as symptoms persisting three months or more after a SARS-CoV-2 infection, it impacts people of all ages, including children, even after mild or asymptomatic cases. First identified in 2020, Long COVID has driven over 24,000 scientific studies, making it one of the most researched conditions in recent history.
In This Article:
Symptoms and Subtypes
Long COVID is a multisystem condition with over 200 reported symptoms affecting the brain, heart, lungs, and more. Common symptoms include fatigue (30.5%), brain fog (16.9%), memory decline (27.9%), shortness of breath, and post-exertional malaise (worsening symptoms after activity). A 2022 study identified four subtypes: one with heart and kidney issues, another with respiratory and sleep problems (mostly women), and others with neurological or musculoskeletal symptoms. In children, headaches (57%) and trouble focusing (44%) are prevalent, while adolescents report low energy. Symptoms can last months or years, with 71% of UK cases persisting over a year.
Causes and Mechanisms
Research points to multiple causes: persistent SARS-CoV-2 viral proteins in blood (found in 43% of patients with cardiopulmonary or neurological symptoms), immune dysregulation, microscopic blood clotting, and reactivation of latent viruses like Epstein-Barr. A 2024 study confirmed viral antigens in blood years post-infection, suggesting persistent infection as a key driver. Other factors include mitochondrial dysfunction and endothelial inflammation, with higher risks in women, older adults, and those with pre-existing conditions. Unvaccinated individuals are twice as likely to develop Long COVID.
Impact and Prevalence
Long COVID affects 10–30% of non-hospitalized, 50–70% of hospitalized, and 10–12% of vaccinated cases. In China, a 2024 study of 74,075 people found fatigue and memory decline most common, less prevalent in single infections. The condition disrupts work and quality of life, with 26.4% of US adults reporting significant activity limitations. Its economic impact is massive, costing $1 trillion annually, or 1% of the global economy.
Management and Prevention
No proven treatments exist, but symptom relief and rehabilitation are key. The Yale New Haven Long COVID Center uses multidisciplinary care involving cardiologists, neurologists, and others. Antiviral trials, like RECOVER-VITAL, are testing if clearing viral remnants helps. Prevention includes vaccination (reducing risk by ~40%), masking in crowded spaces, and prompt antiviral use.
Long COVID remains a complex, debilitating condition with diverse symptoms and causes. While vaccination lowers risk, millions still suffer, urging further research into biomarkers and treatments. Its profound impact on health and economies demands global action.
-By Manoj H